Subarachnoid hemorrhage: Difference between revisions

No edit summary
(Embed Ottawa SAH Calculator on clinical page)
 
(144 intermediate revisions by 22 users not shown)
Line 1: Line 1:
==Epidemiology==
==Background==
*Bleeding into the subarachnoid space (between arachnoid and pia mater)
*Ruptured cerebral aneurysm accounts for ~85% of nontraumatic SAH
**Most common locations: anterior communicating artery (30%), posterior communicating artery (25%), MCA bifurcation (20%)
*Other causes: arteriovenous malformation, perimesencephalic (benign, ~10%), vasculitis, coagulopathy, drug use
*Mortality: ~50% overall (25% die before reaching hospital, 25% die within 30 days)
*Risk factors:
**[[Hypertension]] (most important modifiable risk factor)
**Smoking, heavy alcohol use
**Family history of SAH or aneurysm (first-degree relative)
**Polycystic kidney disease, Ehlers-Danlos, connective tissue disorders
**Prior SAH (risk of rebleeding)
**Sympathomimetic drug use ([[cocaine]], [[amphetamines]])
*Peak incidence: age 40-60; female predominance (1.6:1)


==Clinical Features==
*"Worst headache of my life" — sudden onset, maximal at onset (thunderclap headache)
*'''Sentinel headache''': warning leak days-weeks before major rupture (present in ~30-50%)
*Meningismus (neck stiffness, photophobia) — may take 6-12 hours to develop
*Loss of consciousness at onset (~50%)
*Nausea, vomiting (common)
*Focal neurologic deficits (CN III palsy → posterior communicating artery aneurysm)
*Seizures (~10% at onset)
*Terson syndrome: intraocular hemorrhage (subhyaloid/vitreous) associated with severe SAH
*'''May present as syncope, cardiac arrest, or altered mental status without headache'''


* Of All pts in ED with c/o HA:
===Hunt-Hess Grading===
* 1% will have SAH
*Grade I: asymptomatic or mild headache
* 12% will have SAH if c/o worst HA of life
*Grade II: moderate-severe headache, nuchal rigidity, CN palsy
* 25% will have SAH if c/o worst HA of life + any neuro deficit
*Grade III: drowsiness, confusion, mild focal deficit
*Grade IV: stupor, moderate-severe hemiparesis
*Grade V: coma, decerebrate posturing


Risk Factors (in order of relative risk)
==Differential Diagnosis==
*Primary [[headache]] (migraine, tension, cluster)
*[[Meningitis]] / [[encephalitis]]
*[[Intracerebral hemorrhage]]
*[[Cerebral venous sinus thrombosis]]
*[[Hypertensive emergency]]
*Reversible cerebral vasoconstriction syndrome (RCVS)
*[[Cervical artery dissection]]
*[[Pituitary apoplexy]]


* Genetics (polycystic kidney disease, Ehler-Danlos, family hx)
{{Headache DDX}}
* Hypertension
* Atherosclerosis
* Cigarette smoking
* Alcohol
* Age > 85
* Cocaine use
* Estrogen deficiency
== ==


==Evaluation==
===Non-Contrast CT Head===
*First-line test
*Sensitivity ~98% within 6 hours of onset, ~93% at 12 hours, decreasing to ~50% by day 5-7<ref>Perry JJ, et al. Sensitivity of computed tomography performed within six hours of onset of headache for diagnosis of subarachnoid haemorrhage. ''BMJ''. 2011;343:d4277. PMID 21768192</ref>
*Fisher grade: amount of blood predicts vasospasm risk
*Modern thin-cut CT with experienced radiologist within 6 hours may approach 100% sensitivity


==Clinical Manifestations==
===Lumbar Puncture===
*Required if CT negative and clinical suspicion remains
*Classic finding: xanthochromia (yellow discoloration from bilirubin in CSF)
**Takes 6-12 hours to develop — LP performed <6 hours after onset may miss xanthochromia
*'''Elevated RBCs that do NOT clear''' across sequential tubes (vs traumatic tap which clears)
*Elevated opening pressure
*Traumatic tap vs SAH: controversial; visual xanthochromia and clinical context are most important


===Ottawa SAH Rule===
*For alert patients >15 years with new severe nontraumatic headache reaching maximum intensity within 1 hour
*100% sensitivity (validation study) — if none present, SAH effectively ruled out<ref>Perry JJ, et al. Clinical decision rules to rule out subarachnoid hemorrhage for acute headache. ''JAMA''. 2013;310(12):1248-1255. PMID 24065011</ref>:
**Age ≥40
**Neck pain or stiffness
**Witnessed loss of consciousness
**Onset during exertion
**Thunderclap headache (instant peak)
**Limited neck flexion on exam


* Sudden, severe headache (97% of cases)  
===CT Angiography (CTA)===
* Sudden onset is more important finding than worst HA
*Obtain with initial CT if SAH confirmed or high suspicion
* May be associated with syncope, seizure, nausea/vomiting, and meningismus
*Identifies aneurysm location and morphology for surgical/endovascular planning
* Meningismus may not develop until several hours after bleed (caused by blood breakdown > aseptic meningitis)
*Sensitivity >95% for aneurysms >3 mm
* Retinal hemorrhages
*  May be the only clue in comatose patients
* Approximately 30-50% will have sentinel bleed/HA 6-20 days before SAH
== ==


===Labs===
*CBC, BMP, coagulation studies (PT/INR, PTT)
*Type and screen
*Troponin (neurogenic myocardial stunning)
*Finger stick glucose


==Diagnosis==
==Management==
===ED Management===
*ABCs, IV access, continuous monitoring
*Blood pressure control:
**Target SBP <160 mmHg until aneurysm secured (reduce rebleeding risk)
**Nicardipine infusion (5-15 mg/hr, titrate q5min) — preferred
**Labetalol 10-20 mg IV q10-20min
**Avoid nitroprusside (increases ICP)
*Seizure management: benzodiazepines acutely; prophylactic AEDs controversial
*Treat headache: acetaminophen; short-acting opioids cautiously
**Avoid ketorolac (platelet inhibition)
*Aminocaproic acid (tranexamic acid): may reduce rebleeding risk before aneurysm secured — 4g IV loading dose (discuss with neurosurgery)
*Reverse anticoagulation if applicable


===Definitive Treatment===
*Neurosurgery/neurointerventional consultation emergently
*Aneurysm securing (within 24 hours ideally):
**Endovascular coiling (preferred for most aneurysms) OR
**Surgical clipping
*ICU admission


* Non-Contrast Head CT
===Complications (Post-Hemorrhage)===
* 92% specific if performed w/in 24 hours of bleed
*'''Rebleeding''': highest risk in first 24 hours (~4%); '''most devastating complication'''
* ~100% sensitive if performed w/in 12 hours of bleed
*Vasospasm: occurs days 3-14 (peak day 7); monitor with daily TCDs
* 91% sensitive in patients w/ normal neuro exam
**Treat with nimodipine 60 mg PO/NG q4h x 21 days (improves outcomes; does not prevent vasospasm)
* Decreases to ~50% sensitive by day 5
**Triple-H therapy (hypertension, hypervolemia, hemodilution) — only after aneurysm secured
* Not as sensitive/specific for minor bleeds
*Hydrocephalus: acute (requires EVD) or chronic (VP shunt)
* SAH 2/2 aneurysm (90%) - look in cisterns (especially suprasellar cistern)
*Hyponatremia: cerebral salt wasting vs SIADH
* SAH 2/2 trauma - Look at convexities of frontal & temporal cortices
*Neurogenic cardiac dysfunction: Takotsubo-like, neurogenic pulmonary edema
* Lumbar Puncture
* Mandatory if there is a strong suspicion of SAH despite a normal head CT
* Findings:
* Elevated RBC count that doesn't decrease from tube one to four
* (Decreasing RBCs in later tubes can occur in SAH; only reliable if RBC count in final tube is nl)  
* Opening pressure > 20 in 60% of patients with SAH
* Can help differentiate from a traumatic tap (opening pressure expected to be normal)
* Elevated opening pressure also seen in cerebral venous thrombosis, IIH
* Xanthrochromia
* May help differentiate between SAH and a traumatic tap
* Takes at least 2 hours after the bleed to develop (beware of false negatives)
* Sensitivity (93%) / specificity (95%) highest after 12 hours
* If unable to obtain CSF consider CTA


==Treatment ==
==Disposition==
 
*All confirmed SAH: emergent neurosurgical consultation and ICU admission
 
*Transfer to neurosurgical center if local capabilities unavailable
* Nimodipine
*SAH ruled out (negative CT + negative LP): may discharge with headache precautions and PCP follow-up
* Associated with improved neuro outcomes and decreased cerebral infarction
* Must be given 60mg q4hr PO or NGT only! (never IV)
* BP control
* No consensus on HTN (incr BP may maintain CPP but may also increase rate of bleeding)
* If pt is alert this means CPP is adequate so can try lowering sbp to < 140
* If pt is ALOC consider leaving BP alone, as the ALOC may be 2/2 reduced CPP
* If BP control is necessary, LABETALOL, ESMOLOL or NICARDIPINE is preferred
* Avoid vasodilators such as nitroprusside or NTG (increase cerebral blood volume --> increased ICP)
* Discontinue/reverse all anticoagulation!
* Seizure prophylaxis
* Controversial; some evidence suggests anti-epileptic drugs may worsen outcomes; 3 day course may be preferable
* Glucocorticoid therapy
* Controversial; available evidence suggests is neither beneficial nor harmful
* Glycemic control
* Controversial; consider sliding scale if long pt stay in ED while awaiting ICU bed
* Avoid hypovolemia
 
==Complications==
 
 
* Rebleeding
* Risk is highest within first 24 hours (2.5-4%), particularly within first 6 hours
* Usually diagnosed by CT after acute deterioration in neuro status
* Only aneurysm treatment is effective in preventing rebleeding
* Vasospasm
* Leading cause of death and disability after rupture
* Typically begins no earlier than day three after hemorrhage
* Characterized by decline in neuro status
* Aggressive treatment can only be initiated after the aneurysm has been treated (sx or intraluminal tx)
* Triple-H therapy (hemodilution + induced hypertension (pressors) + hypervolemia)
* Cardiac abnormalities (?2/2 release of catecholamines due to hypoperfusion of hypothalamus)
* Ischemia
* Elevated troponin (20-40% of cases)
* ST segment depression
* Rhythm disturbances
* Torsades, a fib, a flutter
* QT prolongation
* Deep, symmetric TWI
* Prominent U waves
* Hydrocephalus
* Consider ventricular drain placement for deteriorating LOC + no improvement within 24 hours
* Hyponatremia
* Usually due to SIADH
* Treat via isotonic, or if necessary, hypertonic saline (do not treat via water restriction!)
 
==Grading (Hunt and Hess)==
 
 
Grade 0: Unruptured aneurysm
 
Grade 1:  Asymptomatic or mild HA and slight nuchal rigidity
 
Grade 1a:  No acute meningeal/brain reaction, with fixed neurological def
 
Grade 2:  Moderate to severe headache, stiff neck, no neurologic deficit except cranial nerve palsy
 
Grade 3: Mild mental status change (drowsy or confused), mild focal neurologic deficit
 
Grade 4: Stupor or moderate to severe hemiparesis
 
Grade 5:  Coma or decerebrate rigidity
 
*Grade 1 or 2 have curable dz, if dx missed pts return w/ higher grade (ie 3 or 4), 2/3 will be dead or vegetative at 6 mos if grade 3 or 4!
 
*Add one grade for serious sytemic dz (HTN, DM, severe stherosclerosis, COPD)
 
== ==


== Calculators ==
{{Ottawa SAH Calculator}}
{{Fisher Scale Calculator}}


==See Also==
==See Also==
*[[Intracerebral hemorrhage]]
*[[Subdural hemorrhage]]
*[[Epidural hemorrhage]]
*[[Headache]]
*[[Thunderclap headache]]
*[[Lumbar puncture]]


==References==
<references/>
*Connolly ES Jr, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline from the AHA/ASA. ''Stroke''. 2012;43(6):1711-1737. PMID 22556195
*Edlow JA, et al. Diagnosis of subarachnoid hemorrhage. ''Stroke''. 2023;54(4):1058-1072. PMID 36848423
*van Gijn J, et al. Subarachnoid haemorrhage. ''Lancet''. 2007;369(9558):306-318. PMID 17258671


Neuro: Intracranial Hemorrhage
[[Category:Neurology]]
 
[[Category:Critical Care]]
== ==
[[Category:Neurosurgery]]
 
 
==Source==
 
 
7/09 PANI (Adapted from Lampe, Birnbaumer), UpToDate, EB Emergency Medicine, July 2009
 
 
 
 
[[Category:Neuro]]

Latest revision as of 09:56, 22 March 2026

Background

  • Bleeding into the subarachnoid space (between arachnoid and pia mater)
  • Ruptured cerebral aneurysm accounts for ~85% of nontraumatic SAH
    • Most common locations: anterior communicating artery (30%), posterior communicating artery (25%), MCA bifurcation (20%)
  • Other causes: arteriovenous malformation, perimesencephalic (benign, ~10%), vasculitis, coagulopathy, drug use
  • Mortality: ~50% overall (25% die before reaching hospital, 25% die within 30 days)
  • Risk factors:
    • Hypertension (most important modifiable risk factor)
    • Smoking, heavy alcohol use
    • Family history of SAH or aneurysm (first-degree relative)
    • Polycystic kidney disease, Ehlers-Danlos, connective tissue disorders
    • Prior SAH (risk of rebleeding)
    • Sympathomimetic drug use (cocaine, amphetamines)
  • Peak incidence: age 40-60; female predominance (1.6:1)

Clinical Features

  • "Worst headache of my life" — sudden onset, maximal at onset (thunderclap headache)
  • Sentinel headache: warning leak days-weeks before major rupture (present in ~30-50%)
  • Meningismus (neck stiffness, photophobia) — may take 6-12 hours to develop
  • Loss of consciousness at onset (~50%)
  • Nausea, vomiting (common)
  • Focal neurologic deficits (CN III palsy → posterior communicating artery aneurysm)
  • Seizures (~10% at onset)
  • Terson syndrome: intraocular hemorrhage (subhyaloid/vitreous) associated with severe SAH
  • May present as syncope, cardiac arrest, or altered mental status without headache

Hunt-Hess Grading

  • Grade I: asymptomatic or mild headache
  • Grade II: moderate-severe headache, nuchal rigidity, CN palsy
  • Grade III: drowsiness, confusion, mild focal deficit
  • Grade IV: stupor, moderate-severe hemiparesis
  • Grade V: coma, decerebrate posturing

Differential Diagnosis

Headache

Common

Killers

Maimers

Others

Aseptic Meningitis

Evaluation

Non-Contrast CT Head

  • First-line test
  • Sensitivity ~98% within 6 hours of onset, ~93% at 12 hours, decreasing to ~50% by day 5-7[1]
  • Fisher grade: amount of blood predicts vasospasm risk
  • Modern thin-cut CT with experienced radiologist within 6 hours may approach 100% sensitivity

Lumbar Puncture

  • Required if CT negative and clinical suspicion remains
  • Classic finding: xanthochromia (yellow discoloration from bilirubin in CSF)
    • Takes 6-12 hours to develop — LP performed <6 hours after onset may miss xanthochromia
  • Elevated RBCs that do NOT clear across sequential tubes (vs traumatic tap which clears)
  • Elevated opening pressure
  • Traumatic tap vs SAH: controversial; visual xanthochromia and clinical context are most important

Ottawa SAH Rule

  • For alert patients >15 years with new severe nontraumatic headache reaching maximum intensity within 1 hour
  • 100% sensitivity (validation study) — if none present, SAH effectively ruled out[2]:
    • Age ≥40
    • Neck pain or stiffness
    • Witnessed loss of consciousness
    • Onset during exertion
    • Thunderclap headache (instant peak)
    • Limited neck flexion on exam

CT Angiography (CTA)

  • Obtain with initial CT if SAH confirmed or high suspicion
  • Identifies aneurysm location and morphology for surgical/endovascular planning
  • Sensitivity >95% for aneurysms >3 mm

Labs

  • CBC, BMP, coagulation studies (PT/INR, PTT)
  • Type and screen
  • Troponin (neurogenic myocardial stunning)
  • Finger stick glucose

Management

ED Management

  • ABCs, IV access, continuous monitoring
  • Blood pressure control:
    • Target SBP <160 mmHg until aneurysm secured (reduce rebleeding risk)
    • Nicardipine infusion (5-15 mg/hr, titrate q5min) — preferred
    • Labetalol 10-20 mg IV q10-20min
    • Avoid nitroprusside (increases ICP)
  • Seizure management: benzodiazepines acutely; prophylactic AEDs controversial
  • Treat headache: acetaminophen; short-acting opioids cautiously
    • Avoid ketorolac (platelet inhibition)
  • Aminocaproic acid (tranexamic acid): may reduce rebleeding risk before aneurysm secured — 4g IV loading dose (discuss with neurosurgery)
  • Reverse anticoagulation if applicable

Definitive Treatment

  • Neurosurgery/neurointerventional consultation emergently
  • Aneurysm securing (within 24 hours ideally):
    • Endovascular coiling (preferred for most aneurysms) OR
    • Surgical clipping
  • ICU admission

Complications (Post-Hemorrhage)

  • Rebleeding: highest risk in first 24 hours (~4%); most devastating complication
  • Vasospasm: occurs days 3-14 (peak day 7); monitor with daily TCDs
    • Treat with nimodipine 60 mg PO/NG q4h x 21 days (improves outcomes; does not prevent vasospasm)
    • Triple-H therapy (hypertension, hypervolemia, hemodilution) — only after aneurysm secured
  • Hydrocephalus: acute (requires EVD) or chronic (VP shunt)
  • Hyponatremia: cerebral salt wasting vs SIADH
  • Neurogenic cardiac dysfunction: Takotsubo-like, neurogenic pulmonary edema

Disposition

  • All confirmed SAH: emergent neurosurgical consultation and ICU admission
  • Transfer to neurosurgical center if local capabilities unavailable
  • SAH ruled out (negative CT + negative LP): may discharge with headache precautions and PCP follow-up

Calculators

Template:Ottawa SAH Calculator

Modified Fisher Scale

Modified Fisher Scale — SAH Vasospasm Risk
CT Findings Select Grade
Grade

1 Grade 0 — No SAH or IVH (0)

Grade 1 — Thin SAH, no IVH (1)

Grade 2 — Thin SAH with IVH (2)

Grade 3 — Thick SAH, no IVH (3)

Grade 4 — Thick SAH with IVH (4)

Modified Fisher Grade
Interpretation — Risk of Symptomatic Vasospasm
Grade Vasospasm Risk Description
0 | ~0% | No subarachnoid blood detected.
1 | ~24% | Focal or diffuse thin SAH, no intraventricular hemorrhage (IVH).
2 | ~33% | Focal or diffuse thin SAH with IVH.
3 | ~33% | Focal or diffuse thick SAH (>1mm), no IVH.
4 | ~40% | Focal or diffuse thick SAH with IVH. Highest vasospasm risk.
References
  • Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery. 1980;6(1):1-9. PMID 7354892.
  • Frontera JA, Claassen J, Schmidt JM, et al. Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified Fisher scale. Neurosurgery. 2006;59(1):21-27. PMID 16823296.

See Also

References

  1. ↑ Perry JJ, et al. Sensitivity of computed tomography performed within six hours of onset of headache for diagnosis of subarachnoid haemorrhage. BMJ. 2011;343:d4277. PMID 21768192
  2. ↑ Perry JJ, et al. Clinical decision rules to rule out subarachnoid hemorrhage for acute headache. JAMA. 2013;310(12):1248-1255. PMID 24065011
  • Connolly ES Jr, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline from the AHA/ASA. Stroke. 2012;43(6):1711-1737. PMID 22556195
  • Edlow JA, et al. Diagnosis of subarachnoid hemorrhage. Stroke. 2023;54(4):1058-1072. PMID 36848423
  • van Gijn J, et al. Subarachnoid haemorrhage. Lancet. 2007;369(9558):306-318. PMID 17258671
Retrieved from "https://www.wikem.org/w/index.php?title=Subarachnoid_hemorrhage&oldid=389553"